389-40-2 | Sigma-Aldrich

Quality Control Range Sheet- A6042-104 and A6042-204

mL Control 2 1087 – 2258 pg/mL Control 2 461 – 958 pg/mL IL-33 Control 1 389 – 809 pg/mL MIP-1α Control 1

Physiol., 20, 382-389 (2005). 4. Liu Y., et al., Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis. Free Rad. Biol. Med., 40, 960-967 (2006

RABBIT ANTI-GABA

J. Comparative Neurology (1997) 384:580-596. Bae, Y.C., et al., J. Comparative Neurology (1997) 389:127-138. Sherry, D.M. and Townes-Anderson, E., Invest Ophthalmol (2000) 41:2779-2790. Sigurjonsson

Aqueous Solubility Testing with the MultiScreen HTS - PCF Filter Plate

Testosterone 251 292 Phenazopyridene 163 284 2-naphthoic acid >400 >400 Amiloride >400 >400 Amitryptiline >400 389

XP725 Antibody Number-Lot Number 071M4826

e-f g-h 1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80 1.3 9 10 11 12

GOAT ANTI-CHOLINE ACETYLTRANSFERASE (ChAT)

Letters (1992) 147:217-220. 11. Brain Research (1993) 627:49-54 12. Neurobiology of Aging (1993) 14:389-392 13. Cell (1993) 75:1273-1286. 14. Cell (1993) 75:1199-1214. 15. Brain Research (1993) 223

Product Information Sheet - CLL1135

4. Olayioye, M.A., Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Res., 3, 385–389 (2001). 5. Hashizume, T. et al

hTRPV1-HEK293 Recombinant Cell Line

ion channel in the pain pathway Nature 389(6653), 816-824 Clapham, D. E., Runnels, L. W., and Strubing, C. (2001) The TRP ion channel family Nature reviews 2(6), 387-396 Cui, M., Honore, P., Zhong

Rac1/Cdc42 Activation Assay Kit (non-radioactive)

7.4, containing 50% glycerol for a final volume of 300 µL. Anti-Rac1, clone 23A8, Catalog # 05-389, see page two for more information. One vial containing 250 µg of protein G purified mouse IgG2b

Novabiochem Innovations 04/06

463 8100 Italy +39 02 3320311 Macedonia +389 2 3115 122 Netherlands +31 20 4808 400 Norway +47 022 90 Poland +48 22 5359 700 Portugal +351 213600 770 Romania +40 21 444 0903 Russia +70 95 935 7046 Serbia

Rac1 Activation Magnetic Beads Pulldown Assay

beads slurry in PBS containing 50% glycerol for a final volume of 300 µL. 2. Anti-Rac1, clone 23A8: (Part No. 05-389) One vial containing 250 µg of purified IgG2aκ in 250 µL of storage buffer (0.1

p53 And Related Products

the antennapedia leader sequence at the C-terminal . Directly binds to MDM-2 and induces non- apoptotic cell-death (IC50 = 40 mg/ml in TUC-3 cells) 500 mg PRIMA-1 530050 A cell-permeable quinuclidinone

Chromatin Assembly Kit

T and Klug A. (1979) J Cell Biol. 83, 403-27. 2. Kamakaka R, Bulger M and Kadonaga J. (1993) Genes Dev. 7, 1779-95. 3. Luger K et al. (1997) Nature. 389, 251-60. 4. Fyodorov D and Levenstein M. (2002

Rac1/cdc42 Activation Magnetic Beads Pulldown Assay

beads slurry in PBS containing 50% glycerol for a final volume of 300 µL. 2. Anti-Rac1, clone 23A8: (Part No. 05-389) One vial containing 250 µg of purified IgG2aκ in 250 µL of storage buffer (0.1

Bulletin - DAX01

microenvironment. Integrative Biology, 2013. 5(2): p. 381-389. 10. Jeon, J.S., et al., In Vitro Model of Tumor Cell Extravasation. PLoS ONE, 2013. 8(2). 11. Chen, M.B., et al., Mechanisms of tumor

Product Information Sheet - CLL1143

5. Olayioye, M.A., Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members. Breast Cancer Res., 3, 385–389 (2001). 6. Hashizume, T. et al

Estapor®White Microspheres

No. K5-010 0.076-0.125 Styrene copolymer 80 380 210 K5-015 0.126-0.175 Styrene copolymer 39 389 084 Estapor® Quaternary Ammonium-Modified Microspheres [-N+(CH3)3] Product Diameter (µm) Polymer

Human C-Peptide

Tube # Ave CPM % B/Bo ID CPM ng/mL 1 Totals 17717 17737 2  17756 - 3 NSB 415

Spectroquant Move 100 - Overview of preprogrammed methods

Cell test 16 mm 382 Phosphate 00616 1.00616.0001 3.0 – 100.0 mg/l PO4–P H2O Cell test 16 mm 389 Phosphate 00673 1.00673.0001 3.0 – 100.0 mg/l PO4–P H2O Cell test 16 mm 383 Phosphate 14848 1.14848.0001

Method list Spectroquant® Colorimeter Move 100

Cell test 16 mm 382 Phosphate 00616 1.00616.0001 3.0 – 100.0 mg/l PO4–P H2O Cell test 16 mm 389 Phosphate 00673 1.00673.0001 3.0 – 100.0 mg/l PO4–P H2O Cell test 16 mm 383 Phosphate 14848 1.14848.0001

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

287 4 468 4 305 4 389 4 IPI00027737 Melanoma-derived leucine zipper-containing extranuclear factor 50 1 50 1 50 1 50 1 50 1 49 1 IPI00298971 Vitronectin precursor 51 1 112 2 99 2 IPI00329547

Product Information Sheet-tosrtro

665 001 Expand High Fidelity PCR System, dNTPack 100 U, 1 x 100 U, 40 reactions in a final volume of 50 μl 04 738 250 001 500 U, 2 x 250 U, 200 reactions in a final volume of 50

Mouse Metabolic Hormone Expanded Panel

mL) Standard 1 1.4 4.8 8.2 10 11 Standard 2 4.1 14 25 31 33 Standard 3 12 43 74 93 99 Standard 4 37 130 222 278 296 Standard

User Guide

IFNλ2 (pg/mL) IFNλ1 (pg/mL) Standard 1 14 25 4.8 Standard 2 41 74 14 Standard 3 124 222 43 Standard 4 370 667 130 Standard 5 1,111 2,000 389 Standard 6 3,333 6,000 1,167 Standard 7 10,000 18,000 3

User Guide-HIFN130K

IFNλ2 (pg/mL) IFNλ1 (pg/mL) Standard 1 14 25 4.8 Standard 2 41 74 14 Standard 3 124 222 43 Standard 4 370 667 130 Standard 5 1,111 2,000 389 Standard 6 3,333 6,000 1,167 Standard 7 10,000 18,000 3

User Guide

IFNλ2 (pg/mL) IFNλ1 (pg/mL) Standard 1 14 25 4.8 Standard 2 41 74 14 Standard 3 124 222 43 Standard 4 370 667 130 Standard 5 1,111 2,000 389 Standard 6 3,333 6,000 1,167 Standard 7 10,000 18,000 3

Plant Reagents

Components: 10% Sodium dodecyl sulfate solution, 1 mL 10· IP Buffer, 40 mL Microcentrifuge tubes (2 ml), 50 each Protein G Agarose, 2 mL 5 M Sodium chloride solution, 15 mL Spin columns and caps, 50 each

Protocol- MMHE-44K

mL) Standard 1 1.4 4.8 8.2 10 11 Standard 2 4.1 14 25 31 33 Standard 3 12 43 74 93 99 Standard 4 37 130 222 278 296 Standard

pDADMAC Pretreatment Performance Guide

5E6 86% Viability 10E6 86% Viability 15E6 86% Viability Figure 2. Total Cell Density Impacts on Dosing 0 10 20 30 40 50 60 70 80 90

New Products Flyer- Vol 4 Signaling Feature- NEW! Phosphohistidine Antibody

journal Cell* NEW OH 260 160 110 80 60 50 40 30 20 15 10 (kDa) 1 2 OH 260 160 110 80 60 50 40 30 20 15 10 (kDa) 1 2 Description Cat. No. Anti-N1-Phosphohistidine